(Q43438582)

23 November 2017

title

A definite role for treatment with activated protein C in sepsis? Yes. (English)

1 reference

23 November 2017

0 references

1 reference

E Wiel

1

1 reference

23 November 2017

B Vallet

series ordinal

2

1 reference

23 November 2017

language of work or name

1 reference

1 December 2003

1 reference

Journal of Thrombosis and Haemostasis

23 November 2017

published in

1 reference

23 November 2017

volume

1

1 reference

23 November 2017

issue

12

1 reference

23 November 2017

page(s)

2466-2468

1 reference

Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2003.00542.X

Microvascular coagulopathy and disseminated intravascular coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2003.00542.X

Science review: role of coagulation protease cascades in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2003.00542.X

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2003.00542.X

Low levels of protein C are associated with poor outcome in severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2003.00542.X

Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2003.00542.X

21 January 2018

The protein C pathway

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2003.00542.X

Correlation between perioperative blood transfusion and prognosis of patients subjected to surgery for stage I lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2003.00542.X

Risks and benefits of activated protein C treatment for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2003.00542.X

Assessing the use of activated protein C in the treatment of severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2003.00542.X

Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2003.00542.X

10.1111/J.1538-7836.2003.00542.X

21 January 2018

Identifiers

DOI

1 reference

23 November 2017

1 reference